Back

Oral anticoagulation for atrial fibrillation in rheumatic heart disease

European Heart Journal

29 June 2023
Organised by: Logo
Read full article
ESC Journals ARRHYTHMIAS AND DEVICE THERAPY DISEASES OF THE AORTA, PERIPHERAL VASCULAR DISEASE, STROKE Stroke Atrial Fibrillation (AF) VALVULAR, MYOCARDIAL, PERICARDIAL, PULMONARY, CONGENITAL HEART DISEASE Valvular Heart Disease

Contributors

Scott Dougherty
Scott Dougherty

Author

Tseung Kwan O Hospital Tseung Kwan O , Hong Kong

Bruno Nascimento
Bruno Nascimento

Author

Emmy Okello
Emmy Okello

Author

You may be interested in
thumbnail
Congress Presentation
Anticoagulation in rheumatic multivalvular heart disease: what is new?
27 August 2023
thumbnail
Congress Presentation
Deprescribing in older patients with chronic heart failure and atrial fibrillation
29 June 2021
thumbnail
Congress Presentation
Safety and efficacy of anticoagulation therapy post atrial fibrillation ablation
9 March 2024
thumbnail
Congress Presentation
Rhythm control in clinical practice: case presentation
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources